ArticleScientific reports2025
Antioxidant efficiency of Sarcophyton crude extract against gentamicin toxicity in male albino rats.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Combined Exposure to Polystyrene Nanoplastics and Gentamicin Promotes Liver Toxicity Through Oxidative Stress, Inflammation and Apoptotic Pathways: In Vivo and In Silico Studies.Biological trace element research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gentamicin is an antibiotic widely used in treating bacterial infections. However, it's clinical interest is limited by it's toxic side effects on vital organs. Sarcophyton soft coral is a source of natural products with a range of bioactivities. As such, the objective of this work was to assess how well Sarcophyton extract mitigated the gentamicin toxicity in rats. Four equal groups, each with five adult male albino rats, were randomly assigned: the control group, the Sarcophyton group given a Sarcophyton extract dose of 200 mg/kg/day orally for seven days, the gentamicin group receiving an intraperitoneal gentamicin dose of 100 mg/kg/day for seven days, and the combined administration group. Rats that received gentamicin injections saw a fall in body weight along with a decrease in liver function and all hematological parameters except the white blood cell count. The tissue's total antioxidant capacity (TAC) dropped as a result of gentamicin, indicating oxidative stress. Gentamicin additionally caused histological alterations and significant increases in DNA fragmentation levels in the spleen and liver tissues. In contrast, the combined administration of gentamicin and Sarcophyton extract preserved body weight, maintained liver tissue structure and function, and improved hematological markers. Moreover, it strengthened the tissue's TAC, restored the normal structure of the spleen tissues, and decreased the tissue's DNA fragmentation. Sarcophyton's chemical components, identified using gas chromatography-mass spectrometry, have hepatoprotective, antioxidant, and anti-inflammatory qualities, which are responsible for the extract's ameliorative effects. Finally, Sarcophyton extract is a natural medication that may help reduce the toxicity caused by gentamicin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.